0 468

Cited 3 times in

Comparison of Half-Time and Half-Irradiance Photodynamic Therapy in Nonresolving Central Serous Chorioretinopathy

DC Field Value Language
dc.contributor.author이승규-
dc.contributor.author이지환-
dc.date.accessioned2020-06-17T00:31:24Z-
dc.date.available2020-06-17T00:31:24Z-
dc.date.issued2020-03-
dc.identifier.issn1080-7683-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/176006-
dc.description.abstractPurpose: To compare the efficacy of half-time and half-irradiance photodynamic therapy (PDT) in patients with nonresolving central serous chorioretinopathy (CSC) Methods: This retrospective study included 32 patients with nonresolving CSC, of whom 14 were treated with half-time PDT and 18 with half-irradiance PDT. Therapeutic outcomes, including central retinal thickness (CRT), subretinal fluid (SRF) height, subfoveal choroidal thickness (SFCT), thickness of the Haller layer (HL), thickness of the choriocapillaris/Sattler layer (SL), and best-corrected visual acuity (BCVA), were measured at baseline, and at 1 and 3 months after treatment. Results: CRT, SRF, and SFCT decreased significantly at 1 and 3 months after treatment in both groups. Thickness of the HL decreased significantly at 1 and 3 months, whereas thickness of the choriocapillaris/SL did not. BCVA demonstrated a significant improvement at 3 months in both groups. Changes in outcome parameters were not significantly different between the 2 groups. Conclusion: Both half-time and half-irradiance PDT were effective in SRF resolution and visual improvement, reducing choroidal thickness mainly on HL.-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherAssociation For Ocular Pharmacology And Therapeutics-
dc.relation.isPartOfJOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleComparison of Half-Time and Half-Irradiance Photodynamic Therapy in Nonresolving Central Serous Chorioretinopathy-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Ophthalmology (안과학교실)-
dc.contributor.googleauthorJi Hwan Lee-
dc.contributor.googleauthorSung Chul Lee-
dc.contributor.googleauthorChristopher Seungkyu Lee-
dc.identifier.doi10.1089/jop.2019.0003-
dc.contributor.localIdA02913-
dc.contributor.localIdA03222-
dc.relation.journalcodeJ01654-
dc.identifier.eissn1557-7732-
dc.identifier.pmid31825265-
dc.identifier.urlhttps://www.liebertpub.com/doi/abs/10.1089/jop.2019.0003-
dc.subject.keywordcentral serous chorioretinopathy-
dc.subject.keywordchoroid-
dc.subject.keywordphotochemotherapy-
dc.contributor.alternativeNameLee, Christopher Seungkyu-
dc.contributor.affiliatedAuthor이승규-
dc.contributor.affiliatedAuthor이지환-
dc.citation.volume36-
dc.citation.number2-
dc.citation.startPage109-
dc.citation.endPage115-
dc.identifier.bibliographicCitationJOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, Vol.36(2) : 109-115, 2020-03-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Ophthalmology (안과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.